Complementary and alternative medicine use by patients enrolled onto phase I clinical trials.

@article{Dy2004ComplementaryAA,
  title={Complementary and alternative medicine use by patients enrolled onto phase I clinical trials.},
  author={Grace Kho Dy and Lishan Bekele and Lorelei J. Hanson and Alfred Furth and Sumithra J. Mandrekar and Jeff A. Sloan and Araba A. Adjei},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2004},
  volume={22 23},
  pages={4810-5}
}
PURPOSE To describe the prevalence, clinical characteristics, and pattern of use of complementary and alternative medicine (CAM) in patients enrolled onto phase I trials. PATIENTS AND METHODS Questionnaires were administered to 108 patients with advanced malignancies enrolled onto phase I chemotherapy trials at the Mayo Clinic Comprehensive Cancer Center (Rochester, MN). CAM was classified into two modalities, pharmacologic and nonpharmacologic. Clinical and demographic data, including age… CONTINUE READING